DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on July 27, 2005; DOI: 10.1124/dmd.105.005611


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.005611v1
33/11/1603    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fakhoury, M.
Right arrow Articles by Jacqz-Aigrain, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fakhoury, M.
Right arrow Articles by Jacqz-Aigrain, E.


Received for publication May 23, 2005.
Revised July 26, 2005.
Accepted for publication July 26, 2005.

Localization and mRNA expression of CY3A and P-gp in human duodenum as a function of age

May Fakhoury 1, Catherine Litalien 2, Yves Medard 3, Helene Cave 4, Nadia Ezzahir 5, Michel Peuchmaur 6, Evelyne Jacqz-Aigrain 3*

1 Assistance Publique-Hopitaux de Paris 2 Sainte Justine Hospital, Montreal, Canada 3 Paediatric Pharmacology and Pharmacogenetics Unit, Robert Debre hospital, Paris, France 4 Molecular biology Unit, Robert Debre hospital, Paris, France 5 Clinical Epidemiology Unit, Robert Debre hospital, Paris, France 6 Anatomopathology Unit, Robert Debre hospital, Paris, France

* Address correspondence to: E-mail: evelyne.jacqz-aigrain{at}rdb.ap-hop-paris.fr

Abstract

Cytochromes P450 3A (CYP3A) and P-glycoprotein (P-gp) are mainly located in enterocytes and hepatocytes. The CYP3A/P-gp system contributes to the first pass metabolism of many drugs, resulting in a limited bioavailability. During the neonatal period, a shift between CYP3A7, the fetal form, and CYP3A4 occurs in the liver but data on the expression of the CYP3A/P-gp complex in the intestine are very limited. 59 normal duodenal biopsies from Caucasian children aged 1 month to 17 years were studied. Localization of the proteins by immunohistochemistry analysis was performed using a polyclonal antibody "Nuage" anti-CYP3A and a monoclonal antibody "C494" anti-P-gp. The mRNA quantification was performed using highly specific real time RT-PCR. Villin mRNA quantification was used for normalization. CYP3A protein was detected in all enterocytes in the samples from patients over 6 months of age while it was not in younger samples. P-gp protein was expressed at the apical and upper lateral surfaces of the enterocytes. CYP3A isoforms and P-gp mRNA levels were highly variable. CYP3A4 and CYP3A5 mRNA levels were high during the first year of life and decreased with age while CYP3A7 was detected at a low level in 64% of samples, whatever the age. P-gp mRNA expression level was also highly variable. Our results showed that neonates and infants had a significant expression of CYP3A and P-gp mRNA in the intestine, suggesting a different maturation profile of CYP3A and P-gp with age in the liver and the intestine.


Key words: CYP3A, gastrointestinal pharmacology, human CYP enzymes, p-glycoprotein





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.